{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:42Z","timestamp":1772165742142,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang","doi-asserted-by":"crossref","award":["LY14H160010"],"award-info":[{"award-number":["LY14H160010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Medical Science and Technology","award":["2017194140"],"award-info":[{"award-number":["2017194140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systematic retroperitoneal lymphadenectomy has been widely used in the surgical treatment of advanced ovarian cancer patients. Nevertheless, the corresponding therapeutic may not provide a survival benefit. The aim of this study was to assess the effect of systematic retroperitoneal lymphadenectomy in such patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with advanced ovarian cancer (stage III-IV, according to the classification presented by the International Federation of Gynecology and Obstetrics) who were admitted and treated in Zhejiang Cancer Hospital from January 2004 to December 2013 were enrolled and reviewed retrospectively. All patients were optimally or suboptimally debulked (absent or residual tumor &lt;\u20091\u2009cm) and divided into two groups. Group A (no-lymphadenectomy group,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009170): patients did not undergo lymph node resection; lymph nodes resection or biopsy were selective. Group B (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009240): patients underwent systematic retroperitoneal lymphadenectomy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 410 eligible patients were enrolled in the study. The patients\u2019 median age was 51\u2009years old (range, 28\u201372\u2009years old). The 5-year overall survival (OS) and 2-year progression-free survival (PFS) rates were 78 and 24% in the no-lymphadenectomy group and 76 and 26% in the lymphadenectomy group (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.385 and 0.214, respectively). Subsequently, there was no significant difference in 5-year OS and 2-year PFS between the two groups stratified to histological types (serous type or non-serous type), the clinical evaluation of negative lymph nodes or with macroscopic peritoneal metastasis beyond pelvic (IIIB-IV). Multivariate Cox regression analysis indicated that systematic retroperitoneal lymphadenectomy was not a significant factor influencing the patients\u2019 survival. Patients in the lymphadenectomy group had a higher incidence of postoperative complications (incidence of infection treated with antibiotics was 21.7% vs. 12.9% [\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.027]; incidence of lymph cysts was 20.8% vs. 2.4% [\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study showed that systematic retroperitoneal lymphadenectomy did not significantly improve survival of advanced ovarian cancer patients with residual tumor &lt;\u20091\u2009cm or absent after cytoreductive surgery, and were associated with a higher incidence of postoperative complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07144-1","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T08:06:02Z","timestamp":1594627562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients"],"prefix":"10.1186","volume":"20","author":[{"given":"Chenyan","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingqin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"7144_CR1","first-page":"60","volume":"62","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global Cancer statistics. CA A Cancer J Clin. 2011;62:60\u20139.","journal-title":"CA A Cancer J Clin"},{"issue":"5","key":"7144_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jjco\/hys026","volume":"42","author":"Y Xu","year":"2012","unstructured":"Xu Y, Liu Y, Zhou R, et al. LAPTM4B polymorphisms is associated with ovarian Cancer susceptibility and its prognosis. Jpn J Clin Oncol. 2012;42(5):413\u20139.","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"7144_CR3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1447-0756.2011.01826.x","volume":"38","author":"K Sakai","year":"2012","unstructured":"Sakai K, Kajiyama H, Umezu T, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in advanced stage epithelial ovarian carcinoma patients?[J]. J Obstet Gynaecol Res. 2012;38(7):1018\u201323.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"7144_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/00016346609158447","volume":"45","author":"F Bergman","year":"1966","unstructured":"Bergman F. Carcinoma of the ovary. A clinicopathological study of 86 autopsied cases with special reference to mode of spread. Acta Obstet Gynecol Scand. 1966;45(2):211\u201331.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"7144_CR5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.ygyno.2007.01.028","volume":"105","author":"A Pereira","year":"2007","unstructured":"Pereira A, Magrina JF, Rey V, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007;105(3):604\u20138.","journal-title":"Gynecol Oncol"},{"key":"7144_CR6","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","volume":"28","author":"A du Bois","year":"2010","unstructured":"du Bois A, Reuss A, Harter P, PujadeLauraine E, Ray-Coquard I, Pfisterer J. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol. 2010;28:1733\u20139.","journal-title":"J Clin Oncol"},{"key":"7144_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1006\/gyno.1996.0249","volume":"62","author":"F di Re","year":"1996","unstructured":"di Re F, Baiocchi G, Fontanelli R, et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol. 1996;62:360\u20135.","journal-title":"Gynecol Oncol"},{"key":"7144_CR8","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1016\/j.ajog.2006.06.068","volume":"195","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy S, Podratz KC, Cliby WA. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am J Obstet Gynecol. 2006;195:1862\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"7144_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/sj.bjc.6603803","volume":"96","author":"JK Chan","year":"2007","unstructured":"Chan JK, Urban R, Hu JM, et al. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13 918 patients. Br J Cancer. 2007;96:1817\u201322.","journal-title":"Br J Cancer"},{"key":"7144_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1525-1438.1997.00418.x","volume":"7","author":"C Scarabelli","year":"1997","unstructured":"Scarabelli C, Gallo A, Visentin MC, Canzonieri V, Carbone A, Zarrelli A. Systematic pelvic and Para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer. 1997;7:18\u201326.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"7144_CR11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, Sehouli J, Lorusso D, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822.","journal-title":"N Engl J Med"},{"key":"7144_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/jnci\/dji102","volume":"97","author":"PB Panici","year":"2005","unstructured":"Panici PB, Maggioni A, Hacker N, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560\u20136.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"7144_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/GCO.0b013e3282f2fd68","volume":"20","author":"R Angioli","year":"2008","unstructured":"Angioli R, Plotti F, Palaia I, et al. Update on lymphadenectomy in early and advanced ovarian cancer. Curr Opin Obstet Gynecol. 2008;20(1):34\u20139.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"7144_CR14","first-page":"498","volume":"79","author":"PB Pacini","year":"1992","unstructured":"Pacini PB, Scambia G, Baiocchi G, et al. Anatomical study of Para-aortic and pelvic lymph nodes in gynecologic malignanncies. Obstet Gynecol. 1992;79(4):498\u2013502.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"7144_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.AOG.0000249610.95885.ef","volume":"109","author":"JK Chan","year":"2007","unstructured":"Chan JK, Munro EG, Cheung MK, et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007;109(1):12\u20139.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"7144_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0002-9378(86)90817-3","volume":"155","author":"E Burghardt","year":"1986","unstructured":"Burghardt E, Pickel H, Lahousen M, et al. Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol. 1986;155(2):315\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7144_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/jso.2930600403","volume":"60","author":"F Kikkawa","year":"1995","unstructured":"Kikkawa F, Ishikawa H, Tamakoshi K, et al. Prognostic evaluation of lymphadenectomy for epithelial ovarian cancer. J Surg Oncol. 1995;60(4):227\u201331.","journal-title":"J Surg Oncol"},{"issue":"3","key":"7144_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/gyno.1995.1061","volume":"56","author":"NM Spirtos","year":"1995","unstructured":"Spirtos NM, Gross GM, Freddo JL, et al. Cytoreductive surgery in advanced epithelial cancer of the ovary:the impact of aortic and pelvic lymphadenectomy. Gynaecol Oncol. 1995;56(3):345\u201352.","journal-title":"Gynaecol Oncol"},{"issue":"4","key":"7144_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3802\/jgo.2015.26.4.303","volume":"26","author":"H Iwase","year":"2015","unstructured":"Iwase H, Takada T, Iitsuka C, et al. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. J Gynecol Oncol. 2015;26(4):303.","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"7144_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S0002-9378(94)70244-6","volume":"170","author":"E Petru","year":"1994","unstructured":"Petru E, Lahousen M, Tamussino K, et al. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol. 1994;170(2):656\u201362.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"7144_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ygyno.2005.06.051","volume":"99","author":"N Takeshima","year":"2005","unstructured":"Takeshima N, Hirai Y, Umayahara K, et al. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol. 2005;99(2):427\u201331.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07144-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07144-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07144-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:32:13Z","timestamp":1626118333000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07144-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7144"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07144-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14760\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14760\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14760\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14760\/v2","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"12 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.Since this study was a retrospective study, the ethics approval and consent to participate were waived by the Medical Ethics Committee of Zhejiang Cancer Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.No details on individual patients have been reported in the manuscript, so the consent for publication was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"654"}}